Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00486057 · ClinicalTrials.gov registry record
Daclizumab Experience in Pediatric Heart Transplant
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 30
- Enrollment target
NCT00486057 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 30 participants.
The verdict
NCT00486057 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the outcomes of those who have received Daclizumab as part of their immuno-suppression protocol following heart transplantation. Literature suggests that the time to first rejection episode can be avoided or delayed by using induction therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00486057
The ClinicalTrials.gov registry entry for NCT00486057 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00486057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00486057 about?
NCT00486057 is a clinical study titled "Daclizumab Experience in Pediatric Heart Transplant". The purpose of this study is to examine the outcomes of those who have received Daclizumab as part of their immuno-suppression protocol following heart transplantation. Literature suggests that the time to first rejection episode can be avoided or delayed by using induction therapy.
What is the current status of trial NCT00486057?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2004-08. Estimated completion is 2007-11.
Who is sponsoring clinical trial NCT00486057?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.